• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Zinc finger protein 641 (ZNF641)

ACP19280

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19280 Target NameZNF641
Target SynonymsZNF641; Zinc finger protein 641FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-438
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96N77
Background Information
  • Uniprot Id

    Q96N77

  • Target Species

    Human

  • Target Name

    ZNF641

  • Target Full Name

    Zinc finger protein 641

  • Target Function

    Transcriptional activator. Activates transcriptional activities of SRE and AP-1.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    Krueppel C2H2-type zinc-finger protein family

  • Target Tissue Specificity

    Highly expressed in skeletal muscle, moderate expression in heart, liver, and pancreas, lower expression in placenta, no expression seen in brain, lung, and kidney.

  • Target Synonyms

    ZNF641; Zinc finger protein 641

  • Target Background

    Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm.

Inquire Recombinant Human Zinc finger protein 641 (ZNF641) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification